Term
|
Definition
Classification: Antiarrhythmics
Indications: Treatment of CHF. Tachyarrhythmias: atrial fibrillation and atrial flutter
Action: Increased cardiac output and slowing of the heart rate.
Major Side Effects: arrythmias, fatigue, bradycardia, NVD
Routes: PO, IM, IV |
|
|
Term
|
Definition
Classification: Antianginals
Indications: long term prophylatic managment of angina pectoris, treatment of CHF and acute MI.
Action: relief or prevention of anginal attacks. Increased cardiac output. Reduction of blood pressure.
Major Side Effects: dizziness, HA, hypotension, tachycardia.
Routes: PO, IV, SL |
|
|
Term
|
Definition
Classification: Anticoagulants
Indications: Prophylaxis and treatment of various, thromboembolic disorders including: Venous thromboembolism, pulmonary emboli, atrial fibrillation w/embolization.
Action: prevention of thrombus formation.
Major Side Effects: bleeding, anemia, thrombocytopenia
Routes: IV, SQ |
|
|
Term
|
Definition
Classification: allergy cold and cough remedies, bronchodilators
Indications: maintenance therapy of reversible airway obstruction due to COPD, including chronic bronchitis and emphysema
Action: bronchodilation without systemic anticholinergic effects. decreased rhinorrhea
Major Side Effects: dizziness, HA, blurred vusion, sore throat, hypotension, palpitations
Routes: intranasal, inhalation |
|
|
Term
|
Definition
Classification: antiasthmatics, corticosteroids
Indications: maintenance treatment of asthma as prophylatic therapy.
Action: decreased frequency and severity of asthma attacks. improves asthma symptoms.
Major Side Effects: headache, dysphonia, hoarseness
Routes: Inhalation |
|
|
Term
|
Definition
Classification: vasodilator
Indications: acutely decompensated CHF in hospitalized patients who have dyspnea at rest or with minimal activity; has been used w/ digoxin, diuretics and ace inhibitors.
Action: dose-dependent reduction in pulmonary capillary wedge pressure and systemic arterial pressure in patients with heart failure
Major Side Effects: Apnea, hypotension, anxiety
Routes: IV |
|
|
Term
|
Definition
Classification: antiplatlet agent
Indications: reduction of atherosclerotic events in patients at risk for such events including recent MI, acute coronary syndrome, stroke, or peripheral vascular disease.
Action: decreased occurrence of atherosclerotic events in patients at risk.
Major Side Effects: bleeding, neutropenia, thrombotic thrombocytopenic purpura
Routes: PO |
|
|
Term
|
Definition
Classification: anticoagulant
Indications: prophylaxis and treatment of: venous thrombosis, pulmonary embolism, atrial fibrillation w/ embolization.
Action: prevention of thromboembolic events
Major Side Effects: bleeding, nausea, dermal necrosis
Routes: PO, IV |
|
|
Term
|
Definition
Classification: Bronchodilators
Indications: used as a bronchodilator to control and prevent reversible airway obstruction caused by asthma
Action: Bronchodilation
Major Side Effects: nervousness, restlessness, tremor, chest pain, palpitations
Routes: PO, Inhalation |
|
|
Term
|
Definition
Classification: bronchodilator
Indications: long term control of reversible airway obstruction caused by asthma or COPD
Action: Bronchodilation
Major Side Effects: seizures, arrhythymias, tachycardia, anxiety, nausea, vomiting
Routes: PO, IV |
|
|
Term
|
Definition
Classification: Antiasthmatic, Bronchodilator
Indications: Long term control agent in the managment of asthma
Action: decreased frequency and severity of asthma
Major Side Effects: HA, dizziness, CHURG-STRAUSSSYNDROME
Routes: PO |
|
|
Term
metronidazole
(Flagyl, Protostat) |
|
Definition
Classification: Anti-infectives, antiprotozoals, antiulcer agent
Indications: treatment of intra-abdominal infections, gynecological infection, skin and skin structure infections, bone and joint infections, CNS infections.
Action: bactericidal, trichomonacidal, or amebicidal action
Major Side Effects: seizures, dizziness, HA, abdominal pain, anorexia
Routes: PO, IV, topical, vaginal |
|
|
Term
|
Definition
Classification: antiulcer agent, PPI
Indications: maintenance of healing in erosive esophagitis, duodenal ulcers, heartburn, benign gasatric ulcer
Action: diminished accumulation of acid in the gastric lumen w/lessened gastroesophageal reflux, healing of deudenal ulcers
Major Side Effects: abdonimal pain, dizziness, chest pain
Routes: PO |
|
|
Term
|
Definition
Classification: antiulcer agent, Histamine H2 antagonist
Indications: short-term treatment of active duofenal ulcers and benign gastric ulcer, managment of GERD, treatment of heartburn, acid indigestion
Action: healing and prevention of ulcers, decreased symptoms of gastroesophageal reflux. decreased secretion of gastric acid
Major Side Effects: confusion, arrhythmias, aplastic anemia, agranulocytosis
Routes: PO, IM, IV |
|
|
Term
sodium bicarbonate
(Baking Soda) |
|
Definition
Classification: antiulcer agent
Indications: management of metabolic acidosis, used in alkalinize urine and promote excretion of certain drugs in overdosing situations.
Action: alkalinization, neutralization of gastric acid
Major Side Effects: metabolic alkalosis, gastric distention, hypernatremia, hypokalemia, hyopcalcemia
Routes: PO, IV |
|
|
Term
diphenoxylate hydroclorothiazide atropine sulfate
(Lomotil) |
|
Definition
Classification: antidiarrheals
Indications: adjunctive therapy in the treatment of diarrhea
Action: decreased GI motility with subsequent decrease in diarrhea
Major Side Effects: dizziness, constipation, confusion, insomnia
Routes: PO |
|
|
Term
|
Definition
Classification: antiemetics
Indications: prevention of chemotherapy-induced emesis, treatment of postsurgical and diabetic gastric stasis.managment of esophageal reflux. treatmetn of postoperative nausea vomiting
Action: decreased nausea and vomiting, decreased symptoms of gastric stasis. easier passage of nasogastric tube into small bowel.
Major Side Effects: drowsiness, neuroleptic malignant syndrome, restlessness, extrapyramidal reactions.
Routes: PO, IM, IV |
|
|
Term
|
Definition
Classification: Antiemetic
Indications: prevention of nausea and vomiting associated with chemotherapy or radiation therapy, prevention of postoperative NV
Action: decreased incidence and serverity of nausea and vomiting following chemotherapy or surgery
Major Side Effects: HA, constipation, diarrhea, dizziness, fatigue
Routes: PO, IV, IM |
|
|
Term
magnesium hydroxide
(Dulcolax, Milk of Magnesia) |
|
Definition
Classification: mineral and electrolyte replacement/supplements, laxative
Indications: treatment /prevention of hypomagnesemia, bowel evacuant in preparation for surgical/radiographic precedures. milk of magnesia has also been used as an antacid
Action: replacement in deficiency states. Evacuation of the colon.
Major Side Effects: diarrhea, flushing, sweating
Routes: PO |
|
|
Term
|
Definition
Classification: antiflatulents
Indications: relief of painful symptoms of excess gas in the GI tract that may occur postoperativly or as a conquence of peptic ulcer, dyspepsia, diverticullitits
Action: passage of gas through the GI tract by belching or passing flatus
Major Side Effects: none
Routes: PO |
|
|
